Wuidar, V., Dias Da Silva, I., Zielonka, M., Flas, C., & Pequeux, C. (06 February 2024). Does pulsed natural estrogen reduce breast cancer risk? [Poster presentation]. Séminaire Télévie 2024. |
  | Gallez, A., Nys, G., Wuidar, V., Dias Da Silva, I., Taziaux, M., Kinet, V., Tskitishvili, E., Noël, A., Foidart, J.-M., Piel, G., Fillet, M., & Pequeux, C. (03 June 2023). Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment. International Journal of Molecular Sciences, 24 (11), 9718. doi:10.3390/ijms24119718  Peer Reviewed verified by ORBi |
Dias Da Silva, I., Wuidar, V., Nisolle, M., & Pequeux, C. (02 February 2023). Differential effects of menopause hormone therapies on human endometrium and breast cancer [Poster presentation]. Séminaire Télévie 2023. Editorial reviewed |
Wuidar, V., Dias Da Silva, I., & Pequeux, C. (02 February 2023). Does pulsed estrogen therapy reduce breast cancer risk? [Poster presentation]. SéminaireTélévie 2023, Louvain, Belgium. Editorial reviewed |
Dias Da Silva, I., Wuidar, V., Nizet, C., Nisolle, M., & Pequeux, C. (10 November 2022). Deciphering specific estrogen signaling in cell populations of human breast and human endometrium [Poster presentation]. Nuclear Receptor Research Network Meeting, Utrecht, Netherlands. Editorial reviewed |
Wuidar, V., Dias Da Silva, I., & Pequeux, C. (10 November 2022). Does pulsed estrogen therapy recude breast cancer risk? [Poster presentation]. Nuclear Receptor Research Network Meeting, Utrecht, Netherlands. Editorial reviewed |
Wuidar, V. (12 October 2022). 3rd Preclinical and Personnalized Breast Cancer Reasearch Workshop [Paper presentation]. 3rd Preclinical and Personnalized Breast Cancer Reasearch Workshop, Lausanne, Switzerland. |
Wuidar, V., Dias Da Silva, I., & Pequeux, C. (23 September 2022). Does pulsed estrogen therapy reduce breast cancer risk ? [Poster presentation]. International Meeting on Rapid Responses to Steroid Hormones, Paris, France. Editorial reviewed |
Dias Da Silva, I., Wuidar, V., Nizet, C., Nisolle, M., & Pequeux, C. (23 September 2022). Deciphering specific estrogen signaling in cell populations of human breast and human endometrium [Poster presentation]. International Meeting on Rapid Responses to Steroid Hormones. Editorial reviewed |
Dias Da Silva, I., Wuidar, V., Nizet, C., Nisolle, M., & Pequeux, C. (06 September 2022). Deciphering specific estrogen signaling in cell populations of human breast and human endometrium [Poster presentation]. GIGA-Day. Editorial reviewed |
Wuidar, V., Dias Da Silva, I., & Pequeux, C. (06 September 2022). Does pulsed estrogen therapy reduce breast cancer risk ? [Poster presentation]. GIGA-DAY, Liège, Belgium. Editorial reviewed |
Dias Da Silva, I., Wuidar, V., NISOLLE, M., NIZET, C., & Pequeux, C. (May 2022). Deciphering specific estrogen signaling in cell populations of human breast and human endometrium through innovative models [Paper presentation]. 10th French Nuclear Receptors Meeting, Toulouse, France. Editorial reviewed |
Dias Da Silva, I., Wuidar, V., Duysinx, J., Crevet, L., Fioramonti, M., NIZET, C., NISOLLE, M., Van Keymeulen, A., & Pequeux, C. (08 April 2022). Estrogen and analogs signaling in the prevention and treatment of breast cancer [Poster presentation]. Séminaire Télévie, Liege, Belgium. Editorial reviewed |
Wuidar, V., Dias Da Silva, I., Duysinx, J., NIZET, C., & Pequeux, C. (14 December 2021). Human breast organoids: a useful tool to assess breast safety of new menopausal hormone therapy formulations [Poster presentation]. Giga-Cancer Day, Liège, Belgium. Editorial reviewed |
Wuidar, V., Dias Da Silva, I., Duysinx, J., NIZET, C., & Pequeux, C. (12 November 2021). Human breast organoids: a promising model to assess breast safety of new menopausal hormone therapy formulations [Paper presentation]. 14th Congress of the European Society of Gynecology, Venise, Italy. Editorial reviewed |
  | Gallez, A., Dias Da Silva, I., Wuidar, V., Foidart, J.-M., & Pequeux, C. (September 2021). Estetrol and Mammary Gland: Friends or Foes? Journal of Mammary Gland Biology and Neoplasia, 26 (3), 297 - 308. doi:10.1007/s10911-021-09497-0 Peer Reviewed verified by ORBi |
Dias Da Silva, I., Wuidar, V., Duysinx, J., NISOLLE, M., & Pequeux, C. (2021). Patient-derived xenograft (PDX) of endometrium: a promising model to assess endometrium safety of new menopausal hormone treatments [Poster presentation]. GIGA Cancer Day. Editorial reviewed |
Dias Da Silva, I., Wuidar, V., Duysinx, J., NISOLLE, M., & Pequeux, C. (2021). Patient-derived xenograft (PDX) of endometrium: a promising model to assess endometrium safey of new menopausal hormone treatments [Paper presentation]. 14th Congress of the European Society of Gynecology, Venise, Italy. Editorial reviewed |
Wuidar, V., Gillot, L., Dias Da Silva, I., Lebeau, A., Gallez, A., & Pequeux, C. (2021). Sex-based differences in the tumor microenvironment. In Tumor Microenvironment - Novel Concepts. Springer Nature. doi:10.1007/978-3-030-73119-9_23 Peer reviewed |